DISPERSYN GERRIT (Chief Development Officer) reported 1 transaction at PHIO PHARMACEUTICALS CORP.
Review the transaction codes below to understand the nature of each event.
Filed: 3/3/2022ACC: 0001209191-22-015893
Officer· Chief Development Officer
Since Aug 2018
-8.95K
Net shares
Net seller
$7.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.95K disposed
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
−8.95K
Price / share
$0.82
Trade value
$7.35K
% of position
4.0%
3/1/2022
221.28K→212.33K
Total
Net shares
−8.95K
Net value
-$7.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 3/1/2022 | F · Tax Withholding | −8.95K | $0.82 | $7.35K | 4.0% | 221.28K | 212.33K |
| Total | −8.95K | -$7.35K | ||||||
Derivative Transactions0
No derivative transactions reported